Albumin-binding tag derived Exendin-4 analogue for treating hyperglycemia and diabetic complications
Current study was conducted to design and screen a long-lasting Exendin-4 analog for treating type 2 diabetes via the novel strategy of albumin binding combined with thrombin enzymolysis. Firstly, a series of fusion peptides, containing different albumin-binding tags, a determinate thrombin-cleavabl...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/afad88e87b4d4802b9a0a4bd3de12f00 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!